门诊鼻整形术后镇痛:阿片类与非甾体抗炎药的前瞻性随机对照试验
结果显示NSAID组在术后第0天非劣于阿片类组,第1天疼痛评分更低,第7天两组差异无统计学意义;结论认为NSAID是鼻整形术后镇痛可接受且安全的替代选择。
要点
- 布洛芬400mg在鼻整形术后第0天镇痛效果非劣于氢可酮5mg/对乙酰氨基酚325mg。
- 术后第1天布洛芬组平均疼痛评分低于阿片类组,第7天两组差异无统计学意义。
- 两组停药时间无显著差异,无NSAID相关不良反应,可考虑减少或取消阿片类处方。
核心结论
- NSAID(布洛芬)是鼻整形术后镇痛可接受且安全的阿片类替代方案,部分患者可能获得更好的总体疼痛控制。
- 鉴于当前阿片类 epidemic,可考虑显著减少或取消阿片类处方。
研究设计与样本
- 术后第1、2、7天评估数字疼痛评分及镇痛药使用频率和剂量,证据等级为治疗性II级。
主要发现
- 两组性别(p=0.81)和年龄(p=0.61)无显著差异。
- 术后第0天NSAID组疼痛评分(均值±SD,2.54±1.57)非劣于阿片类组(均值±SD,3.14±1.75;p=0.003)。
- 术后第1天NSAID组平均疼痛评分(均值±SD,1.84±1.29)低于阿片类组(均值±SD,2.46±1.90;p=0.01)。
- 术后第7天NSAID组(均值±SD,3.29±2.14)与阿片类组(均值±SD,3.14±2.12;p=0.17)疼痛评分差异无统计学意义。
临床怎么用
- 门诊鼻整形术后可优先考虑使用布洛芬400mg进行镇痛,以减少阿片类处方。
- 需告知患者若NSAID镇痛不足可升级为阿片类,本研究中5例发生升级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The misuse and abuse of opioids, including overprescription, has led to the current opioid epidemic and national crisis. There is a national effort to eliminate the unnecessary prescription of opioids for analgesia. METHODS: Seventy patients were randomized to receive postoperative analgesia with either 5 mg hydrocodone with 325 mg acetaminophen (opioid control group) or 400 mg of ibuprofen [nonsteroidal antiinflammatory drug (NSAID) experimental group]. Pain levels were assessed on postoperative days 1, 2, and 7. Outcome measures included numeric pain rating scores and assessments of frequency and amount of analgesic used. RESULTS: There was no significant difference in gender (p = 0.81) or age (p = 0.61) between groups. On postoperative day 0, the NSAID group (mean ± SD, 2.54 ± 1.57) was found to be noninferior to the opioid group (mean ± SD, 3.14 ± 1.75; p = 0.003). On postoperative day 1, the NSAID group showed a lower mean pain score (mean ± SD, 1.84 ± 1.29) than the opioid group (mean ± SD, 2.46 ± 1.90; p = 0.01). However, on postoperative day 7, the difference in pain scores between the NSAID (mean ± SD, 3.29 ± 2.14) and opioid (mean ± SD, 3.14 ± 2.12; p = 0.17) groups lost statistical significance. There was no significant difference in mean day of medication cessation between the NSAID (mean ± SD, 4.73 ± 1.57) and opioid (mean ± SD, 4.28 ± 2.23; p = 0.26) groups. Seventy-six percent of patients who were prescribed opioids took fewer than eight tablets. Five patients escalated from NSAIDs to opioids. There were no adverse effects related to NSAID use. CONCLUSIONS: NSAIDs are an acceptable and safe alternative to opioids for postoperative analgesia in rhinoplasty and potentially lead to better overall pain control in some patients. Significantly reducing or eliminating opioid prescriptions may be considered in light of the current opioid epidemic. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
引用
- Frants A, Garber D, Lafer MP, et al. Prospective Randomized Trial Comparing Opioids versus Nonsteroidal Antiinflammatory Drugs for Postoperative Analgesia in Outpatient Rhinoplasty. Plast Reconstr Surg. 2021. PMID: 33370050. doi:10.1097/PRS.0000000000007427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。